Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: soya oil; egg lecithin; medium chain triglycerides; glycerol; sodium oleate; water for injections - because of the difficulty in titrating small volumes, propofol-lipuro 2% should not be used in children aged from one month to 3 years.,induction of general anaesthesia in children and adults propofol-lipuro is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older.,maintenance of general anaesthesia in children and adults propofol-lipuro is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older.,propofol-lipuro 1% may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided.,propofol has no analgesic properties.,use for sedation during intensive care in adults propofol-lipuro may also be used in patients >16 years for sedation of ventilated patients receiving intensive care.,conscious sedation for surgical and diagnostic procedures propofol-lipuro may also be used for monitored conscious sedation for surgical and diagnostic procedures in,? propofol-lipuro 1%: adults and children aged one month and older. ? propofol-lipuro 2%: adults and children aged 3 years and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: water for injections; glycerol; medium chain triglycerides; sodium oleate; soya oil; egg lecithin - because of the difficulty in titrating small volumes, propofol-lipuro 2% should not be used in children aged from one month to 3 years.,induction of general anaesthesia in children and adults propofol-lipuro is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older.,maintenance of general anaesthesia in children and adults propofol-lipuro is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older.,propofol-lipuro 1% may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided.,propofol has no analgesic properties.,use for sedation during intensive care in adults propofol-lipuro may also be used in patients >16 years for sedation of ventilated patients receiving intensive care.,conscious sedation for surgical and diagnostic procedures propofol-lipuro may also be used for monitored conscious sedation for surgical and diagnostic procedures in,? propofol-lipuro 1%: adults and children aged one month and older. ? propofol-lipuro 2%: adults and children aged 3 years and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - olive oil, quantity: 50 g; fish oil - rich in omega-3 acids, quantity: 30 g; medium chain triglycerides, quantity: 60 g; soya oil, quantity: 60 g - injection, intravenous infusion - excipient ingredients: glycerol; sodium oleate; dl-alpha-tocopherol; water for injections; egg lecithin; sodium hydroxide - supply of energy and essential fatty acids to patients, as part of a parenteral nutrition regimen, when oral or enteral nutrition is impossible, insufficient or contra-indicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - olive oil, quantity: 50 g; fish oil - rich in omega-3 acids, quantity: 30 g; medium chain triglycerides, quantity: 60 g; soya oil, quantity: 60 g - injection, intravenous infusion - excipient ingredients: glycerol; sodium oleate; dl-alpha-tocopherol; water for injections; egg lecithin; sodium hydroxide - supply of energy and essential fatty acids to patients, as part of a parenteral nutrition regimen, when oral or enteral nutrition is impossible, insufficient or contra-indicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - olive oil, quantity: 50 g; fish oil - rich in omega-3 acids, quantity: 30 g; medium chain triglycerides, quantity: 60 g; soya oil, quantity: 60 g - injection, intravenous infusion - excipient ingredients: glycerol; sodium oleate; dl-alpha-tocopherol; water for injections; egg lecithin; sodium hydroxide - supply of energy and essential fatty acids to patients, as part of a parenteral nutrition regimen, when oral or enteral nutrition is impossible, insufficient or contra-indicated.

Canada - English - Health Canada

hospira healthcare ulc - safflower oil; soybean oil; egg phospholipids - emulsion - 10%; 10%; 1.2% - safflower oil 10%; soybean oil 10%; egg phospholipids 1.2% - caloric agents

Canada - English - Health Canada

hospira healthcare ulc - soybean oil; egg phospholipids; safflower oil - emulsion - 5%; 0.9%; 5% - soybean oil 5%; egg phospholipids 0.9%; safflower oil 5% - caloric agents

Canada - English - Health Canada

hospira healthcare ulc - safflower oil; soybean oil; egg phospholipids - emulsion - 5.0g; 5.0g; 700mg - safflower oil 5.0g; soybean oil 5.0g; egg phospholipids 700mg - caloric agents

Kenya - English - Pharmacy and Poisons Board

aculife healthcare pvt ltd commerce house-v, besides vodafone house, prahlad - intravenous fat emulsion (10%w/v) (soyabean oil… - infusion - each 100 ml contains soyabean oil usp 10.0 gm - other nutrients:

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - soya bean oil ; glucose monohydrate; alanine ; arginine ; aspartic acid; glutamic acid ; glycine; histidine; isoleucine ; leucine ; lysine hydrochloride ; methionine ; phenylalanine; proline; serine; threonine ; tryptophan; tyrosine; valine ; calcium chloride 2 h2o ; sodium glycerophosphate anhydrous; magnesium sulphate 7h2o; potassium chloride; sodium acetate 3 h20 ; amino acids; nitrogen; fat; glucose; glucose (dextrose); sodium; potassium; magnesium; calcium; phosphate; sulphate; chloride; acetate - emulsion for infusion - percent weight/volume - solutions for parenteral nutrition; combinations